| P50 | author | Alessio Signori | Q42684924 |
| P2093 | author name string | A Rambaldi | |
| | M P Sormani | |
| | F Fagioli | |
| | F Ciceri | |
| | A Bacigalupo | |
| | N Sacchi | |
| | R Oneto | |
| | R Crocchiolo | |
| P2860 | cites work | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 |
| | Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation | Q70149552 |
| | Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle | Q73399570 |
| | Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial | Q73687742 |
| | Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry | Q77941016 |
| | Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation | Q82946218 |
| | Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire | Q85112569 |
| | Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies | Q30423572 |
| | Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis | Q34337007 |
| | Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning | Q34404171 |
| | High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation | Q34582448 |
| | Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria | Q34707280 |
| | Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma | Q36013444 |
| | Tutorial in biostatistics: competing risks and multi-state models | Q36619509 |
| | Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate | Q44094549 |
| | Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen | Q44370136 |
| | Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation | Q44888557 |
| | Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. | Q45076113 |
| | Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. | Q46845322 |
| | Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. | Q53563028 |
| | Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 |
| | A Proportional Hazards Model for the Subdistribution of a Competing Risk | Q56885139 |
| | Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors | Q57918913 |
| | HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry | Q59281238 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 1474-1478 | |
| P577 | publication date | 2012-04-02 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors | |
| P478 | volume | 47 | |